Research & Development in
Zug
266 companies in Research & Development based in Zug — name and year of registration from the commercial register.
50 of 266 companies
Holcim Technology Ltd
Since 1976 · 101–500 empl.4.7(22)
Holcim Technology Ltd provides building materials and building solutions, including decarbonized cement, circular aggregates and ready-mix concrete, for infrastructure, industrial and building applications. It also focuses on decarbonizing construction and on energy-efficient building systems and surfacing solutions.
Inoiv GmbH
Since 2017 · 1–10 empl.4.7(543)
The company's core activity is the development, manufacture and distribution of cosmetic products, particularly hair products, facial creams and dermarollers, with a focus on natural ingredients and animal testing-free, dermatologically tested products.
Wolke, Candoo Labs
Since 2016 · 1–10 empl.4.5(45)
Wolke, Candoo Labs is an international blockchain ecosystem builder that provides coworking and private offices, an accelerator program, event and meeting spaces, and advisory and company-setup services.
Dotphoton AG
Since 2018 · 11–20 empl.5.0(4)
The core activity of Dotphoton AG is the development and provision of products and solutions for the efficient management and compression of image and sensor data, particularly in the field of artificial intelligence (AI) and machine learning (ML). The company's products and solutions aim to reduce the costs and time required for processing and storing image and sensor data in various industries such as life sciences, automotive, and earth observation.
Premier Research Group SA
Since 1997 · 1–10 empl.
Premier Research Group SA is a clinical research and consulting provider for the life sciences sector. The company supports the development of drugs, medical devices, and diagnostics through services in study design, clinical development, regulatory strategy, and technology.
Corza Device GmbH
Since 2001 · 1–10 empl.
Corza Device GmbH develops and distributes surgical solutions for a range of medical specialties. The company offers products and services in biosurgery, biomedical textiles, ophthalmology, and wound closure.
BJH - Natur- und Resonanzforschung AG
Since 2003 · 1–10 empl.
BJH Europe is engaged in the development, manufacture and distribution of health products, particularly dietary supplements, care products and cosmetics based on natural ingredients, which are intended to support human health and well-being. The company's core activity lies in the research, development and marketing of products that promote and strengthen the health of the heart, brain, gut, skin and other areas of the body.
Novelpharm AG
Since 2006 · 1–10 empl.
The core activity of Novelpharm is the research and development of products based on natural solutions for diseases, as well as the marketing and distribution of these products.
Lowalt Technologies AG
Since 2006 · 1–10 empl.
Lowalt Technologies AG develops and supplies hardware, software and data systems for the low‑altitude economy, including a Drone Mothership System with modular smart racks and AI‑enabled drone swarms. The company provides strategy, deployment, operations and data‑analysis services for use cases such as smart cities, logistics, energy, maritime, defense and disaster relief.
Olympic Therapeutics AG
Since 2008 · 1–10 empl.
Olympic Therapeutics AG develops bacteriophages for the treatment of MRSA and other bacterial infections, focusing on research and development of therapeutic phage candidates. The company’s activities include identification and development of phage candidates, intellectual property protection, and preparation for clinical development and commercialization.
Meditrial Europe AG
Since 2009 · 11–20 empl.
The core activity of Meditrial is the conduct of clinical trials and the provision of services for medical research, particularly for the MedTech, Pharma and Biotech industries. This includes, among other things, the planning and conduct of clinical trials, regulatory consulting, market access strategy and the provision of digital solutions for clinical research. Meditrial also acts as a representative for companies in various countries and offers services such as data management, risk assessment and emergency plans.
RS DYNAMICS GmbH
Since 2010 · 1–10 empl.
The core activity of RS DYNAMICS is the development and manufacture of specialized devices and technologies for various application areas, in particular: 1. Security: Explosive and drug detection devices, as well as combination devices for the detection of explosives and radioactive materials. 2. Earth Sciences: Technology and instruments for mapping and monitoring soil and groundwater pollution. 3. Medical Technology: Devices for the early detection of cancer, particularly breast cancer, as well as instruments to support researchers in medical technology. The company also offers customer-specific solutions and services in these areas.
AssesSurgery GmbH
Since 2013 · 1–10 empl.
AssesSurgery GmbH is a web-based service supporting surgeons and researchers interested in surgical quality improvement. It provides postoperative complication grading (Clavien‑Dindo), tools to assess overall morbidity, cost-prediction calculators, and the BAR score for liver transplantation risk matching. The platform offers online calculators and individual assistance for using and managing these tools and operates as an independent non‑profit organization.
CRISPR Therapeutics AG
Since 2013 · 101–500 empl.
The core activity of CRISPR Therapeutics is the development of gene therapeutic medicines, particularly through the application of CRISPR-Cas9 technology, to cure diseases at the molecular level. The company focuses on developing medicines for various diseases such as sickle cell anemia, β-thalassemia, cancer, autoimmune disorders, and regenerative medicine.
Alnylam Switzerland GmbH
Since 2015 · 21–50 empl.
The company is a pharmaceutical or biotechnology company specializing in the development and manufacture of medicines for rare diseases. The core activity includes research and development of RNAi-based therapies, the manufacture and marketing of medicines, as well as the provision of patient services, including genetic counseling and patient advocacy.
Sarepta International Holdings GmbH
Since 2017 · 1–10 empl.
The core activity of Sarepta Therapeutics is the development and manufacturing of gene therapies for the treatment of rare diseases, particularly muscular dystrophies such as Duchenne muscular dystrophy, limb-girdle muscular dystrophy (LGMD), and Charcot-Marie-Tooth disease. The company focuses on researching and developing precision gene medicine and aims to increase efficiency in drug development and shorten the time from laboratory to patient.
Web 3.0 Technologies Stiftung
Since 2017 · 21–50 empl.
The core activity of Web3 Foundation is to promote and support research and development of decentralized web software protocols, particularly in the area of blockchain technologies, with the goal of creating a decentralized and fair internet where users have control over their own data, identity and destiny.
Zinzino IP AG
Since 2017 · 1–10 empl.
Zinzino IP AG offers nutritional supplements, skincare products and home health tests under the Zinzino brand. Its range includes omega supplements, health tests and products for immune support, gut health, skin nutrition and weight management.
Aphaia Pharma AG
Since 2018 · 21–50 empl.
The core activity of Aphaia Pharma AG is the development and marketing of pharmaceuticals, particularly in the fields of life sciences and biotechnology. The company focuses on the research and development of innovative therapeutics and medications, particularly in the areas of microvascular medicine and the treatment of diseases such as obesity and metabolic disorders.
LifeScan Europe GmbH
Since 2018 · 1–10 empl.
LifeScan Europe GmbH develops and markets products and digital solutions for diabetes management. Its portfolio includes blood glucose meters, test strips, lancets, integrated digital health platforms, and hospital point-of-care systems.
Global Power and Propulsion Society
Since 2018 · 11–20 empl.
Global Power and Propulsion Society is a volunteer-led international community and forum for turbomachinery professionals and engineers in industry and academia. The society organises conferences, workshops and training, publishes conference proceedings and a journal, and provides datasets and viewpoint articles to support technical exchange and dissemination of research.
Insmed Switzerland GmbH
Since 2019 · 11–20 empl.
Insmed Corporation focuses on the development and commercialization of drugs for rare and serious diseases, particularly in the areas of respiratory diseases and rare diseases. The core activities include research and development of new drugs, the acquisition and licensing of clinical and commercial assets, the conduct of clinical trials, and the commercialization of drugs in the US, Europe, Japan, and other regions.
G&L Scientific (Schweiz) GmbH
Since 2019 · 11–20 empl.
G&L Scientific (Schweiz) GmbH operates an integrated product development and market access platform providing consulting and services to pharmaceutical, biopharmaceutical and biotechnology companies. Services include pharmaceutical and clinical development, regulatory submissions, market access, commercialization, and quality and compliance support.
PlantingSpace AG
Since 2019 · 11–20 empl.
The core activity of PlantingSpace AG encompasses the development of software and technologies, particularly in the areas of: Cloud infrastructure and DevOps practices, Research and development in symbolic processing, compilers, and programming languages, Development of inference algorithms for artificial intelligence models, Frontend development for web applications. The company appears to focus on developing technical solutions for various areas, particularly in software development and artificial intelligence.
Deciphera Pharmaceuticals (Schweiz) AG
Since 2019 · 101–500 empl.
The core activity of Deciphera Pharmaceuticals, LLC is the development and manufacture of cancer treatments, particularly through the development of kinase inhibitors that target specific enzymes involved in the development and spread of cancer.
GOWID AG Green our World Industries Development
Since 2019 · 11–20 empl.
The core activity of GOWI GROUP is the development and global placement of technologies for the material treatment of raw materials, in particular the VDI technology, which enables the recovery of valuable raw materials from waste products such as used tires and their application in various industrial sectors such as water, food, construction and raw materials industries.
Nektar Therapeutics Europe GmbH
Since 2021 · 1–10 empl.
Nektar Therapeutics Europe GmbH develops novel therapies for autoimmune and inflammatory diseases according to the information presented on the website. Its work focuses on immune modulation, including investigational medicines targeting regulatory T cells and other immunology pathways.
DEFI Stiftung
Since 2021 · 1–10 empl.
The core activity of StiftungSchweiz is to provide an online platform and digital tools for philanthropy, particularly for foundations, non-profit organizations and companies, to enable effective, networked and transparent donations and sponsorships.
Jazz Pharmaceuticals Switzerland GmbH
Since 2021 · 1–10 empl.
Jazz Pharmaceuticals Switzerland GmbH is a biopharmaceutical company that develops and commercializes medicines. It focuses on treatments for patients with limited or no options, including therapies in rare disease, neuroscience (e.g., epilepsy) and oncology.
Orchard Therapeutics (Switzerland) GmbH
Since 2021 · 1–10 empl.
Orchard Therapeutics (Switzerland) GmbH develops gene therapies for rare inherited diseases. Its work focuses on ex vivo HSC gene therapy, in which a patient’s own blood stem cells are genetically modified outside the body and then reinfused.
Global Liberty Institute
Since 2022 · 21–50 empl.
Global Liberty Institute is a non-profit organization that mentors, connects, and supports young leaders. It organizes programs and events such as Rising Leaders Summits and Policy Forums with a focus on liberty, economic freedom, and free speech.
Nomic Stiftung
Since 2022 · 11–20 empl.
The core activity of Nomic Foundation is to create and provide open-source software for Ethereum development, supporting developers and driving the advancement of the Ethereum ecosystem.
Polimec Stiftung
Since 2022 · 1–10 empl.
Polimec Stiftung operates digital services (website and app) that present investment and contribution opportunities for third‑party projects and carries out verification processes (KYC) linked to wallet addresses. The foundation processes personal data in accordance with Swiss data protection law and provides accompanying features such as newsletters and analytics.
ACROBiosystems AG
Since 2022 · 1–10 empl.
ACROBiosystems AG supplies life-science reagents and services, including recombinant proteins, antibodies, cell lines, cell culture reagents and assay kits. The company also provides GMP-grade materials, custom protein services and analytical/quality-control services to support cell and gene therapy development.
Novotech Clinical Research AG
Since 2023 · 1–10 empl.
Novotech Clinical Research AG is a clinical research organization (CRO) that provides clinical trial and advisory services for biotech and small to mid-sized pharmaceutical companies. The company supports drug development through services including clinical operations, site selection, regulatory consulting, biometrics, laboratory services, and therapeutic expertise.
Piëch Labs AG
Since 2017 · 11–20 empl.
Piëch Labs AG develops high-performance drivetrains and battery technologies for electric sports cars, including immersion cooling for cells and the Track2Charge fast-charging system.
Qualitas AG
Since 2005 · 11–20 empl.5.0(4)
The core activity of Qualitas AG is the development of IT solutions and the provision of services in the field of quantitative genetics for Swiss livestock breeding, particularly in the areas of breeding value estimation, animal breeding and livestock husbandry. This also includes the development of software solutions and mobile apps, support for the digitization of the Swiss livestock industry, as well as the provision of printing and shipping services.
PIX Moving GmbH
Since 2024 · 11–20 empl.
PIX Moving GmbH is a city robotics company that develops autonomous, modular mobility platforms such as RoboBus, RoboTaxi, RoboShop and RoboVan. The company also provides development kits (PIXKIT) and a Robot-as-a-Service offering for configurable mobile spaces, including hardware and software integration support.
Molecular Modelling Laboratory GmbH
Since 2018 · 1–10 empl.
The core activity of Molecular Modelling Laboratory (MML) involves the application of quantum chemical modeling, artificial intelligence (AI), and electron microscopy for the development of immunointerventions and drug development. Specifically, the focus is on researching quantum mechanical processes in immune reactions and applying this knowledge to the therapy of infectious diseases, immune disorders, neurological diseases, and aging processes. Additionally, MML offers services in the field of computer-aided analysis of drugs, including the prediction of crystal structures and the stability of amorphous solids.
Stiftung CHIWI
Since 2022 · 11–20 empl.
The core activity of CHiwi Foundation is to promote scientific research in the fields of space exploration, alternative energy and advanced mathematics by awarding research grants.
Packgene Biotech AG
Since 2024 · 1–10 empl.
Packgene Biotech AG provides contract research and manufacturing services for cell and gene therapies, including AAV and lentivirus packaging, mRNA/LNP and plasmid production, vector design, analytical testing and GMP manufacturing services.
Trialize AG
Since 2022 · 1–10 empl.
Trialize AG provides a Clinical Trial Operating System that integrates EDC, eCOA/ePRO, eConsent, TeleVisits, RTSM, medical coding and lab modules with automation and analytics for study operations. The platform automates study build (protocol → CRFs), query handling, coding and real‑time monitoring and includes predictive models and AI‑assisted workflows.
Crinetics Pharmaceuticals Europe GmbH
Since 2024 · 1–10 empl.
Crinetics Pharmaceuticals Europe GmbH is a pharmaceutical company focused on the discovery, development, and commercialization of novel therapies for endocrine diseases and endocrine-related tumors. Its pipeline includes drug candidates for conditions such as acromegaly, Cushing’s syndrome, congenital adrenal hyperplasia, and neuroendocrine tumors.
Brigitte Moser Bauforschung und Kunstgeschichte GmbH
Since 2022 · 1–10 empl.
The core activity of the company "Brigitte Moser | Bauforschung & Kunstgeschichte" is the provision of services in the field of building research, monument preservation, art and cultural history. Specifically, this includes: building research and monument preservation, creation of local inventories, writing and accompanying publications, mediation of art and culture, conception and accompaniment of exhibition projects. The company thus offers a wide range of services that focus on the research, documentation and mediation of cultural heritage.
FLARM Technology AG
Since 2006 · 11–20 empl.3.0(2)
The core activity of FLARM Technology AG is the development and manufacture of flight safety systems for general aviation and drones, in particular collision warning systems that alert pilots to potential collisions and enable them to react in time.
Dyverto AG
Since 2022 · 1–10 empl.
The core activity of Dyverto AG is to support start-ups and young companies in the field of medical technology, particularly in the cardiovascular area. The company acts as an incubator and accelerator by identifying, developing and accompanying innovative ideas from clinical practice through patenting, prototyping and proof-of-concept phases. The goal is to transfer these ideas into new companies and secure venture capital financing.
MOHE BioTech (Suisse) SA
Since 2023 · 1–10 empl.
The core activity of Mohe BioTech is the development and provision of products and services in the field of biotechnology, which are intended for both professional and personal use.
Tufa AG
Since 2022 · 1–10 empl.
Tufa AG develops solutions in the field of deep learning. The website also provides a contact address for accounting.
Vantage Alloys AG
Since 2022 · 1–10 empl.
The core activity of Vantage Alloys AG is the trade in metals, particularly vanadium and vanadium alloys, as well as the provision of technical services and consulting in the field of metal processing and application. The company also offers research and development projects (R&D) as well as logistics and distribution services.
Reaktoro Research GmbH
Since 2023 · 1–10 empl.
Reaktoro Research GmbH develops Reaktoro, an open-source computational framework in C++ and Python for simulating chemically reactive processes. The software is used for chemical equilibrium, chemical kinetics, and geochemical modelling, including water-gas-rock systems.
Research & Development in Zug
Research & Development in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of October 10, 2026
Research & Development in other places
By canton